MEDIUM · 5.7

CVE-2020-27269

In SOOIL Developments Co., Ltd Diabecare RS, AnyDana-i and AnyDana-A, the communication protocol of the insulin pump and its AnyDana-i and AnyDana-A mobile applications lacks replay protection measure...

Vulnerability Description

In SOOIL Developments Co., Ltd Diabecare RS, AnyDana-i and AnyDana-A, the communication protocol of the insulin pump and its AnyDana-i and AnyDana-A mobile applications lacks replay protection measures, which allows unauthenticated, physically proximate attackers to replay communication sequences via Bluetooth Low Energy.

CVSS Score

5.7

MEDIUM

CVSS:3.1/AV:A/AC:L/PR:N/UI:R/S:U/C:H/I:N/A:N
Attack Vector
ADJACENT_NETWORK
Attack Complexity
LOW
Privileges Required
NONE
User Interaction
REQUIRED
Scope
UNCHANGED
Confidentiality
HIGH
Integrity
NONE
Availability
NONE

Affected Products

VendorProductVersions
SooilAnydana-A Firmware< 3.0
SooilAnydana-A-
SooilAnydana-I Firmware< 3.0
SooilAnydana-I-
SooilDiabecare Rs Firmware< 3.0
SooilDiabecare Rs-

Related Weaknesses (CWE)

References

FAQ

What is CVE-2020-27269?

CVE-2020-27269 is a vulnerability with a CVSS score of 5.7 (MEDIUM). In SOOIL Developments Co., Ltd Diabecare RS, AnyDana-i and AnyDana-A, the communication protocol of the insulin pump and its AnyDana-i and AnyDana-A mobile applications lacks replay protection measure...

How severe is CVE-2020-27269?

CVE-2020-27269 has been rated MEDIUM with a CVSS base score of 5.7/10. Review the CVSS metrics above for detailed severity breakdown.

Is there a patch for CVE-2020-27269?

Check the references section above for vendor advisories and patch information. Affected products include: Sooil Anydana-A Firmware, Sooil Anydana-A, Sooil Anydana-I Firmware, Sooil Anydana-I, Sooil Diabecare Rs Firmware.